Advancements in Manufacturing of CD8-Targeted Fusosomes Enhance Transduction of Resting T Cells In Vitro and In Vivo

被引:0
|
作者
Trudeau, Kyle [1 ]
Shamashkin, Misha [1 ]
Shi, Xiao [1 ]
Dhameliya, Tejsi [1 ]
Donatelli, Joanna [1 ]
Smith, Derek [1 ]
Lloyd, Maxwell [1 ]
Colant, Noelle [1 ]
Gallagher, Kaely [1 ]
Englehart, Andrew [1 ]
Gaikwad, Amey [1 ]
Phadke, Sanket [1 ]
Kleinfeld, Alison [1 ]
Leahy, Michael [1 ]
Mozdzierz, Nicholas [1 ]
Lipsitz, Yonatan [1 ]
Ansu-Gyeabourh, Emelia [1 ]
Hlavaty, Kelan [1 ]
Kowski, Tom [1 ]
Moore, Emerson [1 ]
DeGroot, Andre [1 ]
Scott-Skandera, Matthew [1 ]
Riofrio, Stephanie [1 ]
DeCosta, Mike [1 ]
Cruite, Patricia [1 ]
Amatya, Shirisha [1 ]
Van Hoeven, Neal [1 ]
Green, Jesse [1 ]
Elpek, Kutlu [1 ]
Ruzo, Albert [1 ]
Shah, Jagesh [1 ]
Wong, Athena [1 ]
Charlton, Adam [1 ]
机构
[1] Sana Biotechnol, Seattle, WA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
760
引用
收藏
页码:378 / 378
页数:1
相关论文
共 50 条
  • [21] Memory CD4+ T cells are suppressed by CD8+ regulatory T cells in vitro and in vivo
    Long, Xin
    Cheng, Qi
    Liang, Huifang
    Zhao, Jianping
    Wang, Jian
    Wang, Wei
    Tomlinson, Stephen
    Chen, Lin
    Atkinson, Carl
    Zhang, Bixiang
    Chen, Xiaoping
    Zhu, Peng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (01): : 63 - 78
  • [22] Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics
    Charitidis, Filippos T.
    Adabi, Elham
    Thalheimer, Frederic B.
    Clarke, Colin
    Buchholz, Christian J.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 23 : 359 - 369
  • [23] Effective Engineering of CD8+T Cells from Autoimmune Disease Patients Utilizing a CD8-Targeted Lipid NanoparticleEncoding an Anti-CD19 CAR mRNA(CPTX2309)
    Zhang, Yan
    Ross, Brittany
    Galvan, Diana
    Bao, Yanjie
    Matsuda, Daiki
    Grosskurth, Shaun
    Pinal-Fernandez, Iago
    Casal-Dominguez, Maria
    Adams, Gregor
    Rosenzweig, Michael
    Farzaneh-Far, Ramin
    Karmali, Priya
    Bot, Adrian
    Mammen, Andrew
    Aghajanian, Haig
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1752 - 1753
  • [24] Suppression of alloimmune responses in vitro and in vivo by CD3+CD8-CD4-αβ+ regulatory T cells
    Zhang, ZX
    Yang, L
    Young, KJ
    Zhang, L
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 84 - 85
  • [25] MONITORING EARLY TRANSCRIPTIONAL PROFILES OF CAR T CELL PRODUCTS GENERATED WITH CONVENTIONAL OR CD8-TARGETED LENTIVIRAL VECTORS
    Charitidis, F.
    Adabi, E.
    Thalheimer, F.
    Miskey, C.
    Childs, L.
    Clarke, C.
    Buchholz, C.
    HUMAN GENE THERAPY, 2022, 33 (7-8) : A33 - A34
  • [26] Activated CD4+ T Cells Dramatically Enhance Chemotherapeutic Tumor Responses In Vitro and In Vivo
    Radfar, Soroosh
    Wang, Yixiang
    Khong, Hung T.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (10): : 6800 - 6807
  • [27] Development of a novel, fully human anti-CD19 chimeric antigen receptor for in vivo delivery via CD8-targeted fusosome
    Kinder, Jeremy M.
    Ciarlo, Christie
    Estrada, Chanel Athena
    van Hoeven, Neal
    Chaturvedi, Vandana
    Zipp, Garrett
    Lampano, Aaron
    Johnson, Adam J.
    Elpek, Kutlu
    Fry, Terry J.
    Foster, Aaron E.
    CANCER RESEARCH, 2023, 83 (07)
  • [28] CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo
    Cowley, SC
    Hamilton, E
    Frelinger, JA
    Su, J
    Forman, J
    Elkins, KL
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (02): : 309 - 319
  • [29] Comparative and Functional Evaluation of In Vitro Generated to Ex Vivo CD8 T Cells
    Dervovic, Dzana D.
    Ciofani, Maria
    Kianizad, Korosh
    Zuniga-Pfluecker, Juan Carlos
    JOURNAL OF IMMUNOLOGY, 2012, 189 (07): : 3411 - 3420
  • [30] CD30+T regulatory cells, but not CD30+CD8 T cells, are impaired following brentuximab vedotin treatment in vitro and in vivo
    Heiser, Ryan A.
    Grogan, Bryan M.
    Manlove, Luke S.
    Gardai, Shyra J.
    CANCER RESEARCH, 2018, 78 (13)